• 60 Hits
  • Search Condition : Filter (MeSH = Antineoplastic Agents / administration & dosage)
Species Resource Title
Human and Animal Cells Meth-A(RCB0464) Requirement of the acquired immune system in successful cancer chemotherapy with cis-diamminedichloroplatinum (II) in a syngeneic mouse tumor transplantation model.
Human and Animal Cells KP4(RCB1005) LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.
Human and Animal Cells WEHI-3(RCB0035) , Ba/F3(RCB0805) Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.
Human and Animal Cells HeLa(RCB0007) , MOLT-4(RCB0206) Noninsecticidal parasporal proteins of a Bacillus thuringiensis serovar shandongiensis isolate exhibit a preferential cytotoxicity against human leukemic T cells.
Human and Animal Cells NUGC-4(RCB1939) The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile.
Human and Animal Cells MCF7(RCB1904) , PANC-1(RCB2095) , L929 AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Human and Animal Cells HSC-2(RCB1945) , HSC-4(RCB1902) Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against Human Oral Squamous Cell Carcinoma Cells.
Human and Animal Cells PC-9(RCB4455) Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.
Human and Animal Cells MKN45(RCB1001) Combined drug action of 2-phenylimidazo[2,1-b]benzothiazole derivatives on cancer cells according to their oncogenic molecular signatures.
Human and Animal Cells T98G(RCB1954) Targeting JNK for therapeutic depletion of stem-like glioblastoma cells.
Human and Animal Cells HS-SY-II(RCB2231) ATR Is a Therapeutic Target in Synovial Sarcoma.
Human and Animal Cells HSC-2(RCB1945) , Ca9-22(RCB1976) , SAS(RCB1974) Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo.
Human and Animal Cells Btk^(-) DT40(RCB1468) Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.
Human and Animal Cells Ba/F3 Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor.
Human and Animal Cells MKN45(RCB1001) Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis.
Human and Animal Cells Ba/F3(RCB0805) , LC-2/ad(RCB0440) Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer.
Human and Animal Cells HHUA(RCB0658) PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
Human and Animal Cells HHUA(RCB0658) Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells.
Human and Animal Cells K562(RCB0027) Transport of ribavirin in human myelogenous leukemia cell line K562.
Human and Animal Cells PC-3(RCB2145) , LNCap.FGC(RCB2144) Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects.